Activity Provided By:

University of Cincinnati and RedMedEd

Managing Severe Asthma in the Era of Biologics: Early-Onset Asthma

Overview / Abstract:	In recent years, better understanding of asthma pathophysiology has led to the development of targeted biologics that have improved outcomes for some patients with severe asthma, and the Global Initiative for Asthma (GINA) guidelines now include biologics as a part of its stepwise treatment guidelines for personalized therapy. However, physicians continue to face challenges in determining when to start biologic therapy and which therapy to choose to most effectively manage their patients’ severe asthma symptoms. In this activity, learners will meet Theresa, a 30-year-old woman who was diagnosed with asthma in infancy and whose asthma has been getting worse over the last several months. This activity provides guidance in the following areas: - Determining whether it is appropriate to initiate biologic treatment - Navigating challenges when prescribing biologic therapies - Tailoring treatment using the most appropriate targeted biologic agent - based on patient phenotype and endotype. Following the case presentation, learners will test their ability to apply what they have learned about managing severe asthma in Cranium Challenge.
Expiration	Apr 17, 2021
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Respiratory Therapy CE
Format	Online
Credits / Hours	0.5
Accreditation	ACCME, ABIM
Presenters / Authors / Faculty	Reynold A. Panettieri, Jr., MD—Program Chair Vice Chancellor, Translational Medicine and Science Director, Rutgers Institute for Translational Medicine and Science Professor of Medicine, Rutgers University New Brunswick, New Jersey Emeritus Professor of Medicine, University of Pennsylvania Flavia C. Hoyte, MD Associate Professor of Medicine Allergy/Immunology Fellowship Training Program Division of Allergy/Immunology National Jewish Health University of Colorado Denver, Colorado Michael E. Wechsler, MD, MMSc Professor of Medicine Director, Cohen Family Asthma Institute National Jewish Health Denver, Colorado
Activity Specialities / Related Topics	Pulmonary Medicine / COPD, Pediatrics, Internal Medicine, Immunology / Immunosuppression, Family Medicine, Asthma, Allergies / Allergic Reactions
Sponsors / Supporters / Grant Providers	This educational activity is supported by an educational grant from GlaxoSmithKline.
Keywords / Search Terms	Web-based, Technology, Online, Virtual, Interactive, CME, Free, Free CE, Free CME, RedMedEd, Patient case, Asthma, Allergic, Eosinophilic, Eosinophils, Early Onset, GINA, Phenotype, Endotype, Biomarker, Type 2, Biologic, Anti-IgE, Anti–IL-5, Anti–IL-4, IgE, IL-5, IL-4, Personalized, Diagnosis, Treatment options, Immunotherapy, Targeted therapy

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map